Dr. Todd F. Roberts, MD
Medical Oncology (Medical Oncology Physician)
825 Chalkstone Ave
Providence, RI 02908
Who else practices at this address →
Providence County includes mental health (6% of residents) shortage areas. About shortage areas
At a glance
- Years since graduation
- 32
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
RI license MD14232 · MA license 159677
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Roger Williams Medical Center Providence, RI
Medical groups
- Prospect Chartercare Rwmc, LLC (65 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Payments from drug and device companies
In 2025, 16 companies reported 26 payments worth $958 in total to this clinician.
| Kite Pharma, Inc. | $256 |
|---|---|
| Janssen Biotech, Inc. | $183 |
| Janssen Scientific Affairs, LLC | $90.78 |
| Incyte Corporation | $56.73 |
| Celgene Corporation | $47.45 |
| Adaptive Biotechnologies Corporation | $44.55 |
| Rigel Pharmaceuticals, Inc. | $34.80 |
| Syndax Pharmaceuticals, Inc. | $34.11 |
| Food and Beverage | $858 |
|---|---|
| Education | $99.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. May 14, 2025 | Education DARZALEX; TALVEY; TECVAYLI · Oncology · in-kind | $99.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.